Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218179 · ClinicalTrials.gov registry record
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 200
- Enrollment target
NCT00218179 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 200 participants.
The verdict
NCT00218179 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 known carcinogens. Biomarkers that quantify carcinogen levels and metabolism are a useful tool and available to use. The purpose of this study is to assess the link between tobacco smoke carcinogen biomarkers and the risk of developing lung cancer.
Interventions
- OTHER Non-intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218179
The ClinicalTrials.gov registry entry for NCT00218179 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-intervention is the first listed.
NCT00218179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218179 about?
NCT00218179 is a clinical study titled "Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1". Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 known carcinogens. Biomarkers that quantify carcinogen levels and metabolism are a useful tool and a...
What is the current status of trial NCT00218179?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2005-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00218179?
The interventions under investigation include: Non-intervention (OTHER).
Who is sponsoring clinical trial NCT00218179?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.